INR 12.21
(-0.41%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 90.32 Million INR | -39.73% |
2022 | 149.85 Million INR | 86.47% |
2021 | 80.36 Million INR | 30.54% |
2020 | 61.56 Million INR | -15.93% |
2019 | 73.22 Million INR | 93.02% |
2018 | 37.93 Million INR | -32.22% |
2017 | 55.97 Million INR | -35.18% |
2016 | 86.34 Million INR | 84.73% |
2015 | 46.74 Million INR | 41.23% |
2014 | 33.09 Million INR | -48.98% |
2013 | 64.86 Million INR | 23.36% |
2012 | 52.58 Million INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 28.82 Million INR | 517.56% |
2023 Q2 | 43.15 Million INR | 23.3% |
2023 Q3 | 32.78 Million INR | -24.03% |
2023 Q4 | -6.9 Million INR | -121.05% |
2023 FY | 90.32 Million INR | -39.73% |
2023 Q1 | 34.99 Million INR | 17.3% |
2022 Q1 | 31.21 Million INR | 294.55% |
2022 Q2 | 39.74 Million INR | 27.31% |
2022 Q3 | 48.73 Million INR | 22.63% |
2022 Q4 | 29.83 Million INR | -38.78% |
2022 FY | 149.85 Million INR | 86.47% |
2021 FY | 80.36 Million INR | 30.54% |
2021 Q4 | -16.04 Million INR | -135.21% |
2021 Q3 | 45.57 Million INR | 33.0% |
2021 Q2 | 34.26 Million INR | 84.62% |
2021 Q1 | 18.56 Million INR | 61390.05% |
2020 FY | 61.56 Million INR | -15.93% |
2020 Q4 | 30.18 Thousand INR | -99.92% |
2020 Q3 | 36.13 Million INR | 57.47% |
2020 Q2 | 22.94 Million INR | 448.03% |
2020 Q1 | 4.18 Million INR | -82.9% |
2019 Q1 | 9.92 Million INR | -34.3% |
2019 FY | 73.22 Million INR | 93.02% |
2019 Q4 | 24.48 Million INR | 24.42% |
2019 Q3 | 19.68 Million INR | -14.02% |
2019 Q2 | 22.89 Million INR | 130.68% |
2018 Q3 | 15.1 Million INR | -10.51% |
2018 Q2 | 16.87 Million INR | 0.0% |
2018 Q1 | 16.87 Million INR | -26.11% |
2018 FY | 37.93 Million INR | -32.22% |
2018 Q4 | 15.1 Million INR | 0.0% |
2017 Q3 | 22.83 Million INR | 40.1% |
2017 Q1 | 16.3 Million INR | 0.0% |
2017 Q2 | 16.3 Million INR | 0.0% |
2017 Q4 | 22.83 Million INR | 0.0% |
2017 FY | 55.97 Million INR | -35.18% |
2016 FY | 86.34 Million INR | 84.73% |
2015 FY | 46.74 Million INR | 41.23% |
2014 FY | 33.09 Million INR | -48.98% |
2013 FY | 64.86 Million INR | 23.36% |
2012 FY | 52.58 Million INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.663% |
Hester Biosciences Limited | 1.27 Billion INR | 92.908% |
Aarti Drugs Limited | 8.31 Billion INR | 98.914% |
Aarti Pharmalabs Limited | 5.83 Billion INR | 98.451% |
Albert David Limited | 1.4 Billion INR | 93.585% |
Alembic Limited | 1 Billion INR | 90.969% |
Alkem Laboratories Limited | 52.29 Billion INR | 99.827% |
Bafna Pharmaceuticals Limited | 452.15 Million INR | 80.024% |
Bajaj HealthCare Limited | 1.47 Billion INR | 93.863% |
Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -619.992% |
Brooks Laboratories Limited | 65.62 Million INR | -37.646% |
Eris Lifesciences Limited | 10.42 Billion INR | 99.134% |
FDC Limited | 6.58 Billion INR | 98.629% |
Glenmark Life Sciences Limited | 12.43 Billion INR | 99.274% |
Gufic Biosciences Limited | 4.07 Billion INR | 97.783% |
Hikal Limited | 5.95 Billion INR | 98.484% |
Ind-Swift Limited | 2.17 Billion INR | 95.842% |
Innova Captab Limited | 3.46 Billion INR | 97.393% |
IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 98.086% |
Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 86.159% |
Jubilant Pharmova Limited | 19.64 Billion INR | 99.54% |
Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 95.213% |
Lupin Limited | 125.09 Billion INR | 99.928% |
Mangalam Drugs & Organics Limited | 691.19 Million INR | 86.932% |
Medico Remedies Limited | 262.14 Million INR | 65.545% |
Morepen Laboratories Limited | 6.16 Billion INR | 98.534% |
Nectar Lifesciences Limited | 4.82 Billion INR | 98.127% |
Orchid Pharma Limited | 2.32 Billion INR | 96.107% |
Procter & Gamble Health Limited | 5.78 Billion INR | 98.438% |
RPG Life Sciences Limited | 2.48 Billion INR | 96.362% |
Kilitch Drugs (India) Limited | 620.47 Million INR | 85.443% |
Sigachi Industries Limited | 2 Billion INR | 95.489% |
Solara Active Pharma Sciences Limited | -1.65 Billion INR | 105.455% |
Suven Pharmaceuticals Limited | 4.12 Billion INR | 97.809% |
Themis Medicare Limited | 2.42 Billion INR | 96.268% |
Unichem Laboratories Limited | 4.86 Billion INR | 98.143% |
Wanbury Limited | 1.73 Billion INR | 94.781% |
Windlas Biotech Limited | 1.33 Billion INR | 93.253% |
ZIM Laboratories Limited | 1.26 Billion INR | 92.876% |
Ind-Swift Laboratories Limited | 4.13 Billion INR | 97.815% |
Ipca Laboratories Limited | 48.58 Billion INR | 99.814% |
Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.965% |
Venus Remedies Limited | 2.18 Billion INR | 95.862% |
Sakar Healthcare Limited | 699.58 Million INR | 87.089% |
Aurobindo Pharma Limited | 109.54 Billion INR | 99.918% |
Divi's Laboratories Limited | 32.44 Billion INR | 99.722% |
AstraZeneca Pharma India Limited | 6.22 Billion INR | 98.548% |
Mankind Pharma Limited | 42.19 Billion INR | 99.786% |
Sequent Scientific Limited | 2.97 Billion INR | 96.968% |
Laurus Labs Limited | 15.44 Billion INR | 99.415% |
Neuland Laboratories Limited | 8.24 Billion INR | 98.905% |
J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 99.408% |
Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.87% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.928% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 95.687% |
Wockhardt Limited | 7.72 Billion INR | 98.83% |
Bal Pharma Limited | 770.19 Million INR | 88.273% |
Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.945% |
Bliss GVS Pharma Limited | 3.69 Billion INR | 97.556% |
Par Drugs and Chemicals Limited | 529.13 Million INR | 82.93% |
Caplin Point Laboratories Limited | 9.2 Billion INR | 99.019% |
Shilpa Medicare Limited | 3.56 Billion INR | 97.464% |
Valiant Laboratories Limited | 138.02 Million INR | 34.562% |
Ajanta Pharma Limited | 21.06 Billion INR | 99.571% |
Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | 20.089% |
Granules India Limited | 16.79 Billion INR | 99.462% |
Medicamen Biotech Limited | 495.49 Million INR | 81.771% |
Syncom Formulations (India) Limited | 559.5 Million INR | 83.857% |
Piramal Enterprises Limited | 8.04 Billion INR | 98.877% |
Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.807% |
NATCO Pharma Limited | 25.73 Billion INR | 99.649% |
Suven Life Sciences Limited | -200.79 Million INR | 144.982% |
Krebs Biochemicals & Industries Limited | -108.74 Million INR | 183.058% |
Strides Pharma Science Limited | 14.38 Billion INR | 99.372% |
Indoco Remedies Limited | 8.04 Billion INR | 98.877% |
Alpa Laboratories Limited | 188.89 Million INR | 52.183% |
Lasa Supergenerics Limited | 121.02 Million INR | 25.371% |
Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 76.903% |